Logo image
Sign in
ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
Journal article   Peer reviewed

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

Sheng-Li Lin, Li-Ying Yan, Xin-Tian Zhang, Ju Yuan, Mo Li, Jie Qiao, Zhao-Yi Wang and Qing-Yuan Sun
PLoS One, Vol.5(2), pp.e9013-e9013
2010
PMID: 20126312

Metrics

6 Record Views

Details